Moreover, during studying about the effects of IL-32θ on breast cancer cell proliferation, we have found that Bcl-2, an anti-apoptotic factor which has been proposed as a prognostic marker [39], was totally repressed by IL-32θ in vitro (data not shown). This evidence concerns the gene BCL2 and breast carcinoma.